STAAR Surgical authorizes USD 50 million share repurchase program
Bitget2026/09/24 20:01- STAAR Surgical’s board, at a regularly scheduled meeting, authorized a share repurchase program of up to USD 50 million.
- Buybacks may be executed in the open market, via private transactions, structured agreements, block trades, or Rule 10b5-1 plans.
- Repurchase timing, price, and volume will be set at management’s discretion; the program can be modified, suspended, or ended.
- Program is expected to run for 12 months; funding planned from free cash flow and cash on hand.
- As of July 3, 2026, STAAR reported USD 181.5 million in cash and investments, no debt; about 50,100,000 shares outstanding as of Aug. 7, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US Dollar Index fell below the 101 mark, down 0.13% intraday.

Report: US-Iran conflict disrupts OPEC+ production increase schedule, capacity review postponed to mid-November
According to media reports, the capacity review work by OPEC+ has been delayed. Originally scheduled to be completed by the end of September 2026, it has now been postponed to mid-November. This theoretically still allows OPEC+ to discuss the related results at the plenary meeting in late November. The independent capacity assessment results will directly affect the production caps approved for each member country, and some member countries have already shown significant disagreements regarding quotas, putting pressure on the alliance’s stability.
71% of UK finance leaders expect tokenization to reshape financial services: Lloyds
